Teva and MAbxience Expand Strategic Partnership to Include an Additional Oncology Biosimilar Candidate

GlobeNewswireOct 3 08:30 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsOct 1 20:32 ET · Ratings

Teva Pharmaceutical's US Affiliate Launches Octreotide Acetate for Injectable Suspension

MT NewswiresOct 1 09:43 ET

Teva Announces Launch Of The First And Only Generic Version Of Sandostatin LAR Depot, In The U.S.

BenzingaOct 1 08:31 ET

Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now?

Yahoo FinanceOct 1 03:38 ET

Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 A.m. ET on November 6, 2024

GlobeNewswireSep 30 16:30 ET